Femring and abdominal distension Patient Reports February 10, 2012

Femring Side Effects Report #5623826-5
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 24, 2008. Female patient, 45 years of age, weighting 158.1 lb, was treated with Femring. After drug was administered, patient experienced the following side effects: abdominal discomfort, abdominal distension, abdominal pain , abdominal tenderness, alanine aminotransferase increased, anorexia, aphasia , balance disorder, blood glucose increased. Femring dosage: 0.05 MG,QD; VAGINAL. During the same period patient was treated with CENESTIN, FLEXERIL, IMITREX. Patient recovered.

Femring Side Effects Report #5663427-6
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2008. Female patient, 45 years of age, weighting 158.1 lb, was treated with Femring. After drug was administered, patient experienced the following side effects: abdominal discomfort, abdominal distension, abdominal tenderness, alanine aminotransferase increased, aphasia , balance disorder, blood glucose increased, breast tenderness, confusional state. Femring dosage: .05 MG, QD, VAGINAL. During the same period patient was treated with CENESTIN, FLEXERIL, IMITREX. Patient recovered.

Femring Side Effects Report #5199913-5
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 21, 2006. Female patient, weighting 119.9 lb, was treated with Femring. After drug was administered, patient experienced the following side effects: abdominal distension, alopecia, amnesia, breast tenderness, cardiac pacemaker insertion, crying, disturbance in attention, dysmenorrhoea. Femring dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with COUMADIN, LANOXIN, DILTIAZEM, PROMETRIUM, OXYTROL, POTASSIUM, DIURETICS. Patient recovered.

Femring Side Effects Report #5249126-3
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 08, 2007. Female patient, weighting 119.9 lb, was treated with Femring. After drug was administered, patient experienced the following side effects: abdominal distension, alopecia, amnesia, basal cell carcinoma, breast tenderness, cardiac pacemaker insertion, crying, dermal cyst, disturbance in attention. Femring dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with COUMADIN, LANOXIN, DILTIAZEM, PROMETRIUM, OXYTROL, POTASSIUM ACETATE, DIURETICS. Patient recovered.


Femring Side Effects Report #5564726-9
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 29, 2007. Female patient was treated with Femring. After drug was administered, patient experienced the following side effects: abdominal discomfort, abdominal distension, abdominal tenderness, anorexia, aphasia , balance disorder, breast tenderness, confusional state, decreased appetite. Femring dosage: 0.05MG, QD, VAGINAL. During the same period patient was treated with CENESTIN. Patient recovered.

Femring Side Effects Report #5590591-X
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 27, 2007. Female patient was treated with Femring. After drug was administered, patient experienced the following side effects: abdominal discomfort, abdominal distension, abdominal pain , abdominal tenderness, anorexia, aphasia , balance disorder, breast tenderness. Femring dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with CENESTIN. Patient recovered.